DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies

Abstract

Herpesvirus entry into cells requires the coordinated action of multiple virus envelope glycoproteins, including gH, gL, and gB. For EBV, the gp42 protein assembles into complexes with gHgL heterodimers and binds HLA class II to activate gB-mediated membrane fusion with B cells. EBV tropism is dictated by gp42 levels in the virion, as it inhibits entry into epithelial cells while promoting entry into B cells. The gHgL and gB proteins are targets of neutralizing antibodies and potential candidates for subunit vaccine development, but our understanding of their neutralizing epitopes and the mechanisms of inhibition remain relatively unexplored. Here we studied the structures and mechanisms of two anti-gHgL antibodies, CL40 and CL59, that block membrane fusion with both B cells and epithelial cells. We determined the structures of the CL40 and CL59 complexes with gHgL using X-ray crystallography and EM to identify their epitope locations. CL59 binds to the C-terminal domain IV of gH, while CL40 binds to a site occupied by the gp42 receptor binding domain. CL40 binding to gHgL/gp42 complexes is not blocked by gp42 and does not interfere with gp42 binding to HLA class II, indicating that its ability to block membrane fusion with B cells represents amore » defect in gB activation. Furthermore, these data indicate that anti-gHgL neutralizing antibodies can block gHgL-mediated activation of gB through different surface epitopes and mechanisms.« less

Authors:
ORCiD logo [1];  [2];  [3];  [4];  [2];  [4];  [1]
  1. Stanford Univ. School of Medicine, Stanford, CA (United States)
  2. Univ. of California, Los Angeles, CA (United States)
  3. Northwestern Univ., Chicago, IL (United States); Technische Univ. Munchen, Munich (Germany)
  4. Northwestern Univ., Chicago, IL (United States)
Publication Date:
Research Org.:
SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1439107
Grant/Contract Number:  
AC02-76SF00515; AI119480; AI076183; CA117794
Resource Type:
Accepted Manuscript
Journal Name:
Proceedings of the National Academy of Sciences of the United States of America
Additional Journal Information:
Journal Volume: 114; Journal Issue: 41; Journal ID: ISSN 0027-8424
Publisher:
National Academy of Sciences
Country of Publication:
United States
Language:
English
Subject:
70 PLASMA PHYSICS AND FUSION TECHNOLOGY; herpesvirus; EBV; membrane fusion; neutralizing antibody; glycoprotein complex

Citation Formats

Sathiyamoorthy, Karthik, Jiang, Jiansen, Mohl, Britta S., Chen, Jia, Zhou, Z. Hong, Longnecker, Richard, and Jardetzky, Theodore S. Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies. United States: N. p., 2017. Web. doi:10.1073/pnas.1704661114.
Sathiyamoorthy, Karthik, Jiang, Jiansen, Mohl, Britta S., Chen, Jia, Zhou, Z. Hong, Longnecker, Richard, & Jardetzky, Theodore S. Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies. United States. https://doi.org/10.1073/pnas.1704661114
Sathiyamoorthy, Karthik, Jiang, Jiansen, Mohl, Britta S., Chen, Jia, Zhou, Z. Hong, Longnecker, Richard, and Jardetzky, Theodore S. Fri . "Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies". United States. https://doi.org/10.1073/pnas.1704661114. https://www.osti.gov/servlets/purl/1439107.
@article{osti_1439107,
title = {Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies},
author = {Sathiyamoorthy, Karthik and Jiang, Jiansen and Mohl, Britta S. and Chen, Jia and Zhou, Z. Hong and Longnecker, Richard and Jardetzky, Theodore S.},
abstractNote = {Herpesvirus entry into cells requires the coordinated action of multiple virus envelope glycoproteins, including gH, gL, and gB. For EBV, the gp42 protein assembles into complexes with gHgL heterodimers and binds HLA class II to activate gB-mediated membrane fusion with B cells. EBV tropism is dictated by gp42 levels in the virion, as it inhibits entry into epithelial cells while promoting entry into B cells. The gHgL and gB proteins are targets of neutralizing antibodies and potential candidates for subunit vaccine development, but our understanding of their neutralizing epitopes and the mechanisms of inhibition remain relatively unexplored. Here we studied the structures and mechanisms of two anti-gHgL antibodies, CL40 and CL59, that block membrane fusion with both B cells and epithelial cells. We determined the structures of the CL40 and CL59 complexes with gHgL using X-ray crystallography and EM to identify their epitope locations. CL59 binds to the C-terminal domain IV of gH, while CL40 binds to a site occupied by the gp42 receptor binding domain. CL40 binding to gHgL/gp42 complexes is not blocked by gp42 and does not interfere with gp42 binding to HLA class II, indicating that its ability to block membrane fusion with B cells represents a defect in gB activation. Furthermore, these data indicate that anti-gHgL neutralizing antibodies can block gHgL-mediated activation of gB through different surface epitopes and mechanisms.},
doi = {10.1073/pnas.1704661114},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
number = 41,
volume = 114,
place = {United States},
year = {Fri Sep 22 00:00:00 EDT 2017},
month = {Fri Sep 22 00:00:00 EDT 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 21 works
Citation information provided by
Web of Science

Figures / Tables:

Fig. 1 Fig. 1: CL40 and CL59 inhibition of membrane fusion. (A and B) Inhibition of fusion activity with purified CL40 mAb (lighter color shade) and Fab (darker color shade) using epithelial cells (A) and B cells (B). (C and D) Inhibition of fusion activity with purified CL59 mAb (lighter color shade)more » and Fab (darker color shade) using epithelial cells (C) and B cells (D). For these panels, the x-axis indicates the amount of purified antibody as final concentration in nanomoles. Empty pSG5 plasmid with no gH or gL insert serves as the negative control, and fusion activity with no antibody is set to 100% for HEK 293 epithelial cells (maroon) and Daudi B cells (blue). Each data point is represented by a single experiment titrating the antibody (except negative control). (E and F) Fusion activity expressed as the average from three independent experiments (biological replicates) with a 200 nM final antibody concentration, with fusion activity expressed as percentage with WT and no antibody data point set at 100% for HEK 293 epithelial cells (E) and Daudi B cells (F). In each experiment, the negative control is pSG5 plasmid with no gH or gL insert.« less

Save / Share:

Works referenced in this record:

Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
journal, November 2011


Overview of the CCP 4 suite and current developments
journal, March 2011

  • Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444910045749

Accurate determination of local defocus and specimen tilt in electron microscopy
journal, June 2003


Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes
journal, January 2015

  • Ciferri, Claudio; Chandramouli, Sumana; Donnarumma, Danilo
  • Proceedings of the National Academy of Sciences, Vol. 112, Issue 6
  • DOI: 10.1073/pnas.1424818112

Viral membrane fusion
journal, May 2015


Crystal structure of the conserved herpesvirus fusion regulator complex gH–gL
journal, July 2010

  • Chowdary, Tirumala K.; Cairns, Tina M.; Atanasiu, Doina
  • Nature Structural & Molecular Biology, Vol. 17, Issue 7
  • DOI: 10.1038/nsmb.1837

Appion: An integrated, database-driven pipeline to facilitate EM image processing
journal, April 2009

  • Lander, Gabriel C.; Stagg, Scott M.; Voss, Neil R.
  • Journal of Structural Biology, Vol. 166, Issue 1
  • DOI: 10.1016/j.jsb.2009.01.002

Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
journal, June 1997


Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
journal, February 2013


Structure of the Prefusion Form of the Vesicular Stomatitis Virus Glycoprotein G
journal, February 2007


The Epstein–Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells
journal, January 2008


The Amino Terminus of Epstein-Barr Virus Glycoprotein gH Is Important for Fusion with Epithelial and B Cells
journal, September 2005


Assembly and Architecture of the EBV B Cell Entry Triggering Complex
journal, August 2014


Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus
journal, June 2002

  • Borza, Corina M.; Hutt-Fletcher, Lindsey M.
  • Nature Medicine, Vol. 8, Issue 6
  • DOI: 10.1038/nm0602-594

Structure of Epstein-Barr Virus Glycoprotein 42 Suggests a Mechanism for Triggering Receptor-Activated Virus Entry
journal, February 2009


Epstein-Barr Virus Uses Different Complexes of Glycoproteins gH and gL To Infect B Lymphocytes and Epithelial Cells
journal, July 1998


Structural basis for Epstein–Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins
journal, December 2016

  • Sathiyamoorthy, Karthik; Hu, Yao Xiong; Möhl, Britta S.
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms13557

Epstein-Barr Virus Entry Utilizing HLA-DP or HLA-DQ as a Coreceptor
journal, March 2000


Recent mechanistic and structural insights on class III viral fusion glycoproteins
journal, August 2015

  • Baquero, Eduard; Albertini, Aurélie AV; Gaudin, Yves
  • Current Opinion in Structural Biology, Vol. 33
  • DOI: 10.1016/j.sbi.2015.07.011

Toward the structural genomics of complexes: Crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis
journal, May 2006

  • Strong, M.; Sawaya, M. R.; Wang, S.
  • Proceedings of the National Academy of Sciences, Vol. 103, Issue 21
  • DOI: 10.1073/pnas.0602606103

Structure of a trimeric variant of the Epstein–Barr virus glycoprotein B
journal, February 2009

  • Backovic, Marija; Longnecker, Richard; Jardetzky, Theodore S.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 8
  • DOI: 10.1073/pnas.0810530106

Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody
journal, December 2010

  • Backovic, M.; DuBois, R. M.; Cockburn, J. J.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 52
  • DOI: 10.1073/pnas.1011507107

The KGD Motif of Epstein-Barr Virus gH/gL Is Bifunctional, Orchestrating Infection of B Cells and Epithelial Cells
journal, January 2012


Structural basis for potent antibody-mediated neutralization of human cytomegalovirus
journal, June 2017


Mutations of Epstein-Barr Virus gH That Are Differentially Able To Support Fusion with B Cells or Epithelial Cells
journal, August 2005


Crystal Structure of the Human Cytomegalovirus Glycoprotein B
journal, October 2015


Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies
journal, October 2015


Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1
journal, July 2006


RELION: Implementation of a Bayesian approach to cryo-EM structure determination
journal, December 2012


Class III viral membrane fusion proteins
journal, April 2009

  • Backovic, Marija; Jardetzky, Theodore S.
  • Current Opinion in Structural Biology, Vol. 19, Issue 2
  • DOI: 10.1016/j.sbi.2009.02.012

Epstein–barr virus vaccines
journal, January 2015

  • Cohen, Jeffrey I.
  • Clinical & Translational Immunology, Vol. 4, Issue 1
  • DOI: 10.1038/cti.2014.27

Structure of the Epstein-Barr Virus gp42 Protein Bound to the MHC Class II Receptor HLA-DR1
journal, February 2002


Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex
journal, December 2010

  • Matsuura, H.; Kirschner, A. N.; Longnecker, R.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 52
  • DOI: 10.1073/pnas.1011806108

Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection
journal, September 2010


PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

Two distinct trimeric conformations of natively membrane-anchored full-length herpes simplex virus 1 glycoprotein B
journal, March 2016

  • Zeev-Ben-Mordehai, Tzviya; Vasishtan, Daven; Hernández Durán, Anna
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 15
  • DOI: 10.1073/pnas.1523234113

Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody
journal, September 2015

  • Chandramouli, Sumana; Ciferri, Claudio; Nikitin, Pavel A.
  • Nature Communications, Vol. 6, Issue 1
  • DOI: 10.1038/ncomms9176

Mapping the N-Terminal Residues of Epstein-Barr Virus gp42 That Bind gH/gL by Using Fluorescence Polarization and Cell-Based Fusion Assays
journal, July 2010

  • Liu, F.; Marquardt, G.; Kirschner, A. N.
  • Journal of Virology, Vol. 84, Issue 19
  • DOI: 10.1128/JVI.00381-10

Fusing structure and function: a structural view of the herpesvirus entry machinery
journal, April 2011

  • Connolly, Sarah A.; Jackson, Julia O.; Jardetzky, Theodore S.
  • Nature Reviews Microbiology, Vol. 9, Issue 5
  • DOI: 10.1038/nrmicro2548

The Conserved Disulfide Bond within Domain II of Epstein-Barr Virus gH Has Divergent Roles in Membrane Fusion with Epithelial Cells and B Cells
journal, September 2014

  • Mohl, B. S.; Sathiyamoorthy, K.; Jardetzky, T. S.
  • Journal of Virology, Vol. 88, Issue 23
  • DOI: 10.1128/JVI.02272-14

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
journal, July 1984

  • Fingeroth, J. D.; Weis, J. J.; Tedder, T. F.
  • Proceedings of the National Academy of Sciences, Vol. 81, Issue 14
  • DOI: 10.1073/pnas.81.14.4510

Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion
journal, June 2007


A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL
journal, April 2015

  • Xing, Yi; Oliver, Stefan L.; Nguyen, TuongVi
  • Proceedings of the National Academy of Sciences, Vol. 112, Issue 19
  • DOI: 10.1073/pnas.1501176112

The Large Groove Found in the gH/gL Structure Is an Important Functional Domain for Epstein-Barr Virus Fusion
journal, January 2013

  • Chen, J.; Jardetzky, T. S.; Longnecker, R.
  • Journal of Virology, Vol. 87, Issue 7
  • DOI: 10.1128/JVI.03245-12

Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206

EMAN: Semiautomated Software for High-Resolution Single-Particle Reconstructions
journal, December 1999

  • Ludtke, Steven J.; Baldwin, Philip R.; Chiu, Wah
  • Journal of Structural Biology, Vol. 128, Issue 1
  • DOI: 10.1006/jsbi.1999.4174

Improvement of molecular-replacement models with Sculptor
journal, March 2011

  • Bunkóczi, Gábor; Read, Randy J.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444910051218

Works referencing / citing this record:

Epstein-Barr Virus and the Human Leukocyte Antigen Complex
journal, July 2019


Perspectives of Phage–Eukaryotic Cell Interactions to Control Epstein–Barr Virus Infections
journal, April 2018

  • Górski, Andrzej; Międzybrodzki, Ryszard; Jończyk-Matysiak, Ewa
  • Frontiers in Microbiology, Vol. 9
  • DOI: 10.3389/fmicb.2018.00630

Figures/Tables have been extracted from DOE-funded journal article accepted manuscripts.